Vascular access dysfunction continues to result in substantial morbidity fo
r chronic hemodialysis patients. Pharmacologic and molecular biologic appro
aches to prevention of vascular access dysfunction, if clinically successfu
l, will be cost effective and improve quality of life for chronic dialysis
patients. This review summarizes currently available information and future
prospects in pharmacologic and molecular biologic approaches to preventing
vascular access stenosis, Curr Opin Nephrol Hypertens 8:566-572. (C) 1999
Lippincott Williams & Wilkins.